Journal articles on the topic 'Pharma management'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Pharma management.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Shah, Rita. "Transformation of Regulatory Content Management in Pharma." International Journal of Science and Research (IJSR) 13, no. 2 (2024): 6–10. http://dx.doi.org/10.21275/sr24122131119.
Full textMone, S. P., Jinendra Bafna, Yash Nikam, Shreyas Lokhande, and Prashant Pote. "Pharma Sort." International Journal for Research in Applied Science and Engineering Technology 10, no. 11 (2022): 1669–71. http://dx.doi.org/10.22214/ijraset.2022.47656.
Full textCrainer, Stuart. "PHARMA PLUS." Business Strategy Review 25, no. 1 (2014): 62–67. http://dx.doi.org/10.1111/j.1467-8616.2014.01030.x.
Full textTripathy, Swagat, and Bishnu B. Mohanty. "PROJECT MANAGEMENT VALUES DRIVEN IN PHARMA INDUSTRY." International Journal of Drug Regulatory Affairs 4, no. 2 (2018): 27–32. http://dx.doi.org/10.22270/ijdra.v4i2.183.
Full textKilgallon, William. "The Henley Pharma Forum — Henley Management College." Journal of Medical Marketing 5, no. 4 (2005): 388–90. http://dx.doi.org/10.1057/palgrave.jmm.5040259.
Full textFesta, Giuseppe, Imen Safraou, Maria Teresa Cuomo, and Ludovico Solima. "Big data for big pharma." Business Process Management Journal 24, no. 5 (2018): 1110–23. http://dx.doi.org/10.1108/bpmj-10-2017-0272.
Full textDastidar, Surajit Ghosh, Rahul Thakurta, and Anusha Sreeram. "Health Pharma: managing supply chain." Emerald Emerging Markets Case Studies 2, no. 6 (2012): 1–5. http://dx.doi.org/10.1108/20450621211275156.
Full textMohini C Shinde, Pranali Hatwar, and Gajanan S Sanap. "Recycling and waste management ideas for pharma industry." International Journal of Science and Research Archive 14, no. 1 (2025): 001–15. https://doi.org/10.30574/ijsra.2025.14.1.2640.
Full textAvani, Reddy Alla, T. Cherian Kevin, Surapaneni Ramya, et al. "Present Scenario in Pharma Research and Business Management." International Journal of Toxicological and Pharmacological Research 13, no. 6 (2023): 280–84. https://doi.org/10.5281/zenodo.11201458.
Full textMolé, Ronald B. "Big ‘bad’ pharma." Journal of Medical Marketing 5, no. 3 (2005): 261–63. http://dx.doi.org/10.1057/palgrave.jmm.5040238.
Full textDas Sarkar, Raktimava. "Pharma Software - A Complete Overview." International Journal of Science and Healthcare Research 8, no. 2 (2023): 166–77. http://dx.doi.org/10.52403/ijshr.20230220.
Full textBano, Aksa, G.Sravanthi, and Dr. Dolly Diyana David. "Training And Development At Aurobindo Pharma Ltd." Think India 22, no. 2 (2019): 26–32. http://dx.doi.org/10.26643/think-india.v22i2.7951.
Full textNaima, Afreen, and Jamal Shehla. "Misoprostol: A Pharma Marvel." Research & Review: Drugs and Drugs Development 2, no. 1 (2019): 11–13. https://doi.org/10.5281/zenodo.3470972.
Full textLeyfman, Yan, Erel Joffe, Esther Drill, et al. "Expectant Management of Extranodal Marginal Zone Lymphoma of Bronchial-Associated Lymphoid Tissue (BALT)." Blood 134, Supplement_1 (2019): 2826. http://dx.doi.org/10.1182/blood-2019-123257.
Full textMarinkovic, Valentina, Stana Bekcic, Gordana Pejovic, Tatjana Sibalija, Vidosav Majstorovic, and Ljiljana Tasic. "An approach to TQM evaluation in pharma business." TQM Journal 28, no. 5 (2016): 745–59. http://dx.doi.org/10.1108/tqm-10-2015-0134.
Full textJanzen, William, Elizabeth Admirand, Jeffery Andrews, et al. "Establishing and Maintaining a Robust Sample Management System." SLAS TECHNOLOGY: Translating Life Sciences Innovation 24, no. 3 (2019): 256–68. http://dx.doi.org/10.1177/2472630319834471.
Full textShaik, Rabbani, Lumeena Shaik, and Sreenivasa Prasanna P. "Pharmacovigilance: Need for Indian Pharma Industry." Future Journal of Pharmaceuticals and Health Sciences 3, no. 3 (2023): 341–45. http://dx.doi.org/10.26452/fjphs.v3i3.490.
Full textSyed, Jawad, and Junhua Wang. "Shanghai Silk Pharma Ltd: Employee Turnover." Asian Journal of Management Cases 15, no. 2_suppl (2018): S55—S67. http://dx.doi.org/10.1177/0972820118804969.
Full textAmsbaugh, Pamela, and Dennis A. Pitta. "New product introduction at TyRx Pharma, Inc." Journal of Product & Brand Management 15, no. 7 (2006): 468–72. http://dx.doi.org/10.1108/10610420610712865.
Full textIqbal, Muhammad Anus, Akbar Ali, Iram Liaqat, Muhammad Mudassar, Ghulam Muhayyu Din, and Samyyah Iram. "Management in Healthcare Sector: Artificial Intelligence Methodology in Pharma 4.0." European Journal of Management, Economics and Business 2, no. 2 (2025): 230–40. https://doi.org/10.59324/ejmeb.2025.2(2).20.
Full textHarshada, Kailas Patil, Somnath Chaudhari Hemangi, A. Patil Sunila., and N. Patil Amruta. "A Review on :Hazards in Pharma Industry and Safety Management." A Review on :Hazards in Pharma Industry and Safety Management 1, no. 2 (2024): 30–40. https://doi.org/10.5281/zenodo.12684038.
Full textMuhammad, Anus Iqbal, Ali Akbar, Liaqat Iram, Mudassar Muhammad, Muhayyu Din Ghulam, and Iram Samyyah. "Management in Healthcare Sector: Artificial Intelligence Methodology in Pharma 4.0." European Journal of Management, Economics and Business 2, no. 2 (2025): 230–40. https://doi.org/10.59324/ejmeb.2025.2(2).20.
Full textVan den Bogaert, Sarah, Jana Declercq, Thierry Christiaens, Geert Jacobs, and Piet Bracke. "In the land of pharma: A qualitative analysis of the reputational discourse of the pharmaceutical industry." Public Relations Inquiry 7, no. 2 (2018): 127–47. http://dx.doi.org/10.1177/2046147x18774588.
Full textVasanthan, S. "An In-Depth Financial Performance Analysis and Cash Management Strategy of Solara Active Pharma Sciences Limited: A Case Study (2020-2023)." INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT 09, no. 06 (2025): 1–9. https://doi.org/10.55041/ijsrem51071.
Full textGeva, Ilan, and Laurence Minsky. "The Ethics of Marketing Healthcare Services and Pharma Products During the Pandemic." Journal of Healthcare Management Standards 1, no. 2 (2021): 1–13. http://dx.doi.org/10.4018/jhms.2021070101.
Full textKumar, Ashish, and Dr Priyanka Ranawat. "A Comparative Analysis of Brand Management of Cipla and Sun Pharma." International Journal for Research in Applied Science and Engineering Technology 12, no. 5 (2024): 1522–26. http://dx.doi.org/10.22214/ijraset.2024.61861.
Full textPooja, S. Devkate* Vikas B.Wamane*. "A REVIEW - ARTIFICIAL INTELLIGENCE IN PHARMA INDUSTRY." International Journal in Pharmaceutical Sciences 1, no. 12 (2023): 330–50. https://doi.org/10.5281/zenodo.10373995.
Full textWunder, Gene C. "Brandjacking Big Pharma on the Web." Journal of Internet Commerce 8, no. 1-2 (2009): 58–69. http://dx.doi.org/10.1080/15332860903341323.
Full textHenry, J. "Role of pharma-nutrition in management and treatment of metabolic syndrome." PharmaNutrition 2, no. 3 (2014): 76. http://dx.doi.org/10.1016/j.phanu.2013.11.007.
Full textBoulden, George P., and Richard De Laat. "Peer group learning in roche pharma development." Action Learning: Research and Practice 2, no. 2 (2005): 197–204. http://dx.doi.org/10.1080/14767330500207043.
Full textJohari, Maryam, and Seyyed-Mahdi Hosseini-Motlagh. "Coordination contract for a competitive pharmaceutical supply chain considering corporate social responsibility and pricing decisions." RAIRO - Operations Research 54, no. 5 (2020): 1515–35. http://dx.doi.org/10.1051/ro/2019073.
Full textTakanashi, S., Y. Kaneko, and T. Takeuchi. "SAT0093 CDAI AND DAS28 IN THE MANAGEMENT OF RHEUMATOID ARTHRITIS IN CLINICAL PRACTICE." Annals of the Rheumatic Diseases 79, Suppl 1 (2020): 980.1–980. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1377.
Full textCavicchioli, Sophia, Leonardo Miziara, Camila Pinheiro, Hernane Barud, and Cibele Coury. "Managing Knowledge for Pharma and Biotech Innovation." International Journal of Advances in Medical Biotechnology - IJAMB 6, no. 1 (2024): 11–22. http://dx.doi.org/10.52466/ijamb.v6i1.121.
Full textBehnke, Nils. "Marketing Strategy: How biotechnology and speciality pharma companies can beat big pharma in marketing cancer drugs." Journal of Medical Marketing 5, no. 1 (2005): 10–14. http://dx.doi.org/10.1057/palgrave.jmm.5040195.
Full textLallas, Efthymios N., Ilias Santouridis, Georgios Mountzouris, Vassilis C. Gerogiannis, and Anthony Karageorgos. "An SQWRL-Based Method for Assessing Regulatory Compliance in the Pharmaceutical Industry." Applied Sciences 12, no. 21 (2022): 10923. http://dx.doi.org/10.3390/app122110923.
Full textKhan, Noor Hashim, Yanbing Ju, Muhammad Awais Baloch, and Irfan Uddin. "Pharma macro-environmental risks and organizational self-development." Human Systems Management 38, no. 2 (2019): 149–58. http://dx.doi.org/10.3233/hsm-180360.
Full textMiziara Barboza Ferreira, Leonardo, Lincoln Miziara Barboza Ferreira, Jamily Angela Sant Anna Carvalho, Paulo Yun Cha, and Ana Beatriz Figueiredo Oliveira. "Innovation projects at the University-Pharmaceutical Industry interface: challenges and opportunities." International Journal of Advances in Medical Biotechnology - IJAMB 4, no. 2 (2021): 2–14. http://dx.doi.org/10.52466/ijamb.v4i2.94.
Full textAnthuvan, Thamburaj. "Pharma Marketing 2030: Transforming with Innovation and Skills." Indian Journal of Technical Education 47, Special Issue, No. 1 (2024): 49–53. https://doi.org/10.5281/zenodo.14627658.
Full textMadhumita, Dr G., Dr G. Rajini, and Dr B. Subisha. "Investigation Of Over The Counter (Otc ) Pharmaceutical Brands Prefered By New Age Indian Women." Restaurant Business 118, no. 4 (2019): 1–15. http://dx.doi.org/10.26643/rb.v118i4.7204.
Full textAlt, Rainer, and Thomas Puschmann. "Developing customer process orientation: the case of Pharma Corp." Business Process Management Journal 11, no. 4 (2005): 297–315. http://dx.doi.org/10.1108/14637150510609372.
Full textRahul, Sarda, Mahale Rachappa, and Motipwar Sanjay. "Artificial Intelligence Importance and application in Pharma Industry." Chemistry Research Journal 7, no. 6 (2022): 33–41. https://doi.org/10.5281/zenodo.11532812.
Full textMathur, Neeti, Satish Chandra Tiwari, T. Sita Ramaiah, and Himanshu Mathur. "Capital structure, competitive intensity and firm performance: an analysis of Indian pharmaceutical companies." Managerial Finance 47, no. 9 (2021): 1357–82. http://dx.doi.org/10.1108/mf-01-2020-0009.
Full textSchneikart, Gerald, Walter Mayrhofer, Josef Frysak, and Clemens Löffler. "A Returnable Transport Item to Integrate Logistics 4.0 and Circular Economy in Pharma Supply Chains." Tehnički glasnik 17, no. 3 (2023): 375–82. http://dx.doi.org/10.31803/tg-20230504144856.
Full textLabant, MaryAnn. "Spatial Biology Guides Pharma to New Frontiers." Genetic Engineering & Biotechnology News 42, S1 (2022): 18–21. http://dx.doi.org/10.1089/gen.42.s1.05.
Full textSchiff, Gordon. "Standardized Pill Imprint Codes: A Pharma Fantasy." Journal of Medical Systems 28, no. 1 (2004): 1–7. http://dx.doi.org/10.1023/b:joms.0000021517.51673.f3.
Full textWoods, Jordan, and Radhika Iyengar-Emens. "Blockchain to Secure a More Personalized Pharma." Genetic Engineering & Biotechnology News 39, no. 1 (2019): 27–29. http://dx.doi.org/10.1089/gen.39.01.08.
Full textTyebjee, Tyzoon, and Jill Hardin. "Biotech–pharma alliances: Strategies, structures and financing." Journal of Commercial Biotechnology 10, no. 4 (2004): 329–39. http://dx.doi.org/10.1057/palgrave.jcb.3040091.
Full textRosenberger, Stephan. "Growth of Artificial Intelligence in Pharma Manufacturing." Genetic Engineering & Biotechnology News 43, no. 1 (2023): 34–36. http://dx.doi.org/10.1089/gen.43.01.12.
Full textAndini, Selly, and Januri. "Pengaruh Perencanaan Pajak terhadap Manajemen Laba pada PT. Merapi Utama Pharma Medan." Al-Kharaj: Jurnal Ekonomi, Keuangan & Bisnis Syariah 6, no. 4 (2024): 4979–92. http://dx.doi.org/10.47467/alkharaj.v6i4.858.
Full textKernder, A., H. Morf, P. Klemm, et al. "POS1458-HPR DIGITAL RHEUMATOLOGY IN THE ERA OF COVID-19: RESULTS OF A NATIONAL PATIENT AND PHYSICIAN SURVEY." Annals of the Rheumatic Diseases 80, Suppl 1 (2021): 1013–14. http://dx.doi.org/10.1136/annrheumdis-2021-eular.1328.
Full text